Croda International (LON:CRDA) Posts Quarterly Earnings Results

Key Points

• Croda International reported quarterly earnings of GBX 72.20 ($0.96) per share, with a net margin of 9.98% and return on equity of 6.96%.
• The company has a market capitalization of £3.73 billion and a current ratio of 2.72, indicating strong liquidity.
• Insiders purchased a total of 1,284 shares of company stock in the last quarter, demonstrating confidence in Croda International's growth potential.

Croda International (LON:CRDA - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported GBX 72.20 ($0.96) earnings per share for the quarter, Digital Look Earnings reports. Croda International had a net margin of 9.98% and a return on equity of 6.96%.

Croda International Stock Up 0.6%

CRDA traded up GBX 15 ($0.20) during midday trading on Friday, reaching GBX 2,627 ($34.87). 536,042 shares of the company were exchanged, compared to its average volume of 1,088,552. The company has a debt-to-equity ratio of 30.90, a quick ratio of 2.25 and a current ratio of 2.72. The company has a market cap of £3.67 billion, a price-to-earnings ratio of 22.57, a price-to-earnings-growth ratio of 1.40 and a beta of 0.74. The company's fifty day moving average price is GBX 2,976.24 and its 200 day moving average price is GBX 3,029.35. Croda International has a one year low of GBX 2,527 ($33.54) and a one year high of GBX 4,335 ($57.54).

Insider Activity

In related news, insider Ian Bull bought 1,000 shares of Croda International stock in a transaction on Tuesday, May 6th. The stock was acquired at an average price of GBX 3,011 ($39.97) per share, with a total value of £30,110 ($39,965.49). Also, insider Danuta Gray acquired 1,300 shares of the business's stock in a transaction dated Friday, August 1st. The shares were acquired at an average cost of GBX 2,600 ($34.51) per share, with a total value of £33,800 ($44,863.29). Insiders bought 6,346 shares of company stock valued at $17,310,982 over the last quarter. 0.93% of the stock is owned by insiders.

Analyst Ratings Changes

Several research firms have issued reports on CRDA. Berenberg Bank decreased their price objective on shares of Croda International from GBX 3,800 ($50.44) to GBX 3,100 ($41.15) and set a "buy" rating for the company in a research note on Tuesday. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Croda International from GBX 3,400 ($45.13) to GBX 3,000 ($39.82) and set a "hold" rating for the company in a research report on Tuesday. Citigroup cut their target price on shares of Croda International from GBX 3,550 ($47.12) to GBX 3,300 ($43.80) and set a "neutral" rating for the company in a research note on Tuesday, April 29th. Finally, JPMorgan Chase & Co. upgraded shares of Croda International to an "overweight" rating in a research note on Wednesday.

Croda International Company Profile

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.